Impact Factor
3.40
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.62
831 total citations
h5-index
25
h5 depth signal
Cited share
74.9%
266 of 355
Total citations
831
Citation footprint
Metric signal
2.56
External metric anchor
Self-citation
1.1%
9 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
780
United States
94
Japan
52
United Kingdom
40
Thailand
39
Citing Fields of Research
Hematology
1,060
Lymphomas
271
Immunology
106
Oncology
91
Noncoding RNA
69
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,860
Articles tracked across the journal lifetime
Indexed publication set
355
266 cited publications
Last 12 months
127
10.6 publications/month
Open access share
100.0%
127 OA publications in the last year
Leading citing country
China
780 citing publications
Leading citing field
Hematology
1,060 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v7n1, Feb. 2002-
v7n1, Feb. 2002-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Broad Categories
Hematology
MeSH Descriptors
Hematologic Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/16078454.2026.2749300
Open DOI
Pacak-Zhuang syndrome with EPAS1 p.Pro531Leu somatic variant: one case report and literature review
02
DOI 10.1080/16078454.2026.2746132
Open DOI
Threshold effect of serum 25-hydroxyvitamin D on Anemia risk in U.S. adults aged 45 years and older
03
DOI 10.1080/16078454.2026.2741981
Open DOI
Effects of long-term cryopreservation at −80 °C on the viability and recovery of peripheral blood stem cells
1. Peripheral blood stem cells (PBSCs), mobilised using chemotherapy and/or granulocyte colony-stimulating factor (G-CSF), are used for autologous and allogeneic stem cell transplantation [1]. Seve...
04
DOI 10.1080/16078454.2026.2737562
Open DOI
Development and internal validation of a machine learning model for predicting second primary malignancy risk in hodgkin lymphoma survivors: a population-based competing risk analysis
Hodgkin lymphoma (HL) survivors face an elevated long-term risk of developing second primary malignancies (SPMs), yet accurate prediction tools remain scarce. This study aimed to develop and internally validate a machine learning-based p...
05
06
DOI 10.1080/16078454.2026.2722564
Open DOI
miR-877-5P acts as a tumor suppressor in multiple myeloma by targeting MAPK8: a study on prognostic value and functional mechanism
Multiple myeloma (MM) is the second most prevalent haematologic malignancy, and its incidence has shown a consistent upward trend in recent years [1]. The disease is defined by the clonal expansion...
07
DOI 10.1080/16078454.2026.2733376
Open DOI
Human platelet 5-hydroxyindoleacetic acid concentrations are meager and unlikely to be physiologically active or play a role in inflammation
Recently it has been reported that platelet 5-hydroxyindoleacetic acid (5-HIAA, the principal serotonin metabolite) plays a critical role in the recruitment of neutrophils to sites of infection and...
08
DOI 10.1080/16078454.2026.2730041
Open DOI
Teclistamab-associated adverse events: a disproportionality analysis of the FDA adverse event reporting system
1. Multiple myeloma (MM), defined by clonal expansion of neoplastic plasma cells, represents roughly 11.6% of haematologic malignancies [1]. First-line treatment for MM commonly includes proteasome...
09
10
DOI 10.1080/16078454.2026.2720973
Open DOI
Frontline therapies for adult patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia: a systematic literature review
Acute lymphoblastic leukemia (ALL) is an aggressive form of leukemia of early lymphoid precursors—most frequently of B- or T-cell lineage—characterized by the accumulation of lymphoblasts that supp...
Bibliographical & Catalog Notes
Description based on: Vol. 1, no. 3 (Dec. 1996); title from cover.
Also issued online.